Independent Franchise Partners LLP Merck & Co., Inc. Transaction History

Independent Franchise Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $292 Million - $344 Million	-5,067,641 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $185 Million - $218 Million	-3,647,200 Reduced 41.85%	5,067,641 $308 Million
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $56.8 Million - $66 Million	-1,114,453 Reduced 11.34%	8,714,841 $475 Million
Q4 2017 Feb 13, 2018	BUY	$51.62 - $61.64 $8.72 Million - $10.4 Million	168,975 Added 1.75%	9,829,294 $553 Million
Q3 2017 Oct 23, 2017	BUY	$58.67 - $63.13 $567 Million - $610 Million	9,660,319	9,660,319 $619 Million

3,821

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $244B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Independent Franchise Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Independent Franchise Partners LLP with notifications on news.